These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12682346)

  • 1. Open-label study of donepezil in chronic poststroke aphasia.
    Berthier ML; Hinojosa J; Martín Mdel C; Fernández I
    Neurology; 2003 Apr; 60(7):1218-9. PubMed ID: 12682346
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain injury, cognitive impairment, and donepezil.
    Whitlock JA
    J Head Trauma Rehabil; 1999 Aug; 14(4):424-7. PubMed ID: 10407214
    [No Abstract]   [Full Text] [Related]  

  • 3. Switching cholinesterase inhibitor therapy in Alzheimer's disease--donepezil to rivastigmine, is it worth it?
    Bullock R; Connolly C
    Int J Geriatr Psychiatry; 2002 Mar; 17(3):288-9. PubMed ID: 11921158
    [No Abstract]   [Full Text] [Related]  

  • 4. [Post-marketing observational study of donepezil].
    Ibach B
    Krankenpfl J; 2005; 43(1-3):25. PubMed ID: 15912820
    [No Abstract]   [Full Text] [Related]  

  • 5. An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients.
    Whyte EM; Lenze EJ; Butters M; Skidmore E; Koenig K; Dew MA; Penrod L; Mulsant BH; Pollock BG; Cabacungan L; Reynolds CF; Munin MC
    Cerebrovasc Dis; 2008; 26(3):317-21. PubMed ID: 18667813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
    Black S; Román GC; Geldmacher DS; Salloway S; Hecker J; Burns A; Perdomo C; Kumar D; Pratt R;
    Stroke; 2003 Oct; 34(10):2323-30. PubMed ID: 12970516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label trial of donepezil (aricept) in the treatment of persons with mild traumatic brain injury.
    Kaye NS; Townsend JB; Ivins R
    J Neuropsychiatry Clin Neurosci; 2003; 15(3):383-4; author reply 384-5. PubMed ID: 12928519
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of donepezil on cognitive functioning in Down syndrome.
    Johnson N; Fahey C; Chicoine B; Chong G; Gitelman D
    Am J Ment Retard; 2003 Nov; 108(6):367-72. PubMed ID: 14561111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of low-dose donepezil in schizophrenia.
    Erickson SK; Schwarzkopf SB; Palumbo D; Badgley-Fleeman J; Smirnow AM; Light GA
    Clin Neuropharmacol; 2005; 28(4):179-84. PubMed ID: 16062097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donepezil for Alzheimer's disease in clinical practice--The DONALD Study. A multicenter 24-week clinical trial in Germany.
    Froelich L; Gertz HJ; Heun R; Heuser I; Jendroska K; Kornhuber J; Kurz A; Mueller-Thomsen T; Ries F; Waechtler C; Metz M; Goebel C
    Dement Geriatr Cogn Disord; 2004; 18(1):37-43. PubMed ID: 15084792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.
    Pelton GH; Harper OL; Tabert MH; Sackeim HA; Scarmeas N; Roose SP; Devanand DP
    Int J Geriatr Psychiatry; 2008 Jul; 23(7):670-6. PubMed ID: 18088076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.
    Leroi I; Brandt J; Reich SG; Lyketsos CG; Grill S; Thompson R; Marsh L
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):1-8. PubMed ID: 14716693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical benefits of a new piperidine-class AChE inhibitor.
    Doody RS
    Eur Neuropsychopharmacol; 1999 Apr; 9 Suppl 2():S69-77. PubMed ID: 10332937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol abuse in an elderly woman taking donepezil for Alzheimer disease.
    Marinho V; Laks J; Engelhardt E; Conn D
    J Clin Psychopharmacol; 2006 Dec; 26(6):683-5. PubMed ID: 17110839
    [No Abstract]   [Full Text] [Related]  

  • 15. Donepezil: an update.
    Seltzer B
    Expert Opin Pharmacother; 2007 May; 8(7):1011-23. PubMed ID: 17472546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.
    Minett TS; Thomas A; Wilkinson LM; Daniel SL; Sanders J; Richardson J; Littlewood E; Myint P; Newby J; McKeith IG
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):988-93. PubMed ID: 14618549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA].
    Azanza JR; Sádaba B; Quetglas EG; Escolar M
    Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948
    [No Abstract]   [Full Text] [Related]  

  • 18. Donepezil for Huntington's disease.
    Fernandez HH; Friedman JH; Grace J; Beason-Hazen S
    Mov Disord; 2000 Jan; 15(1):173-6. PubMed ID: 10634264
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial.
    Salloway S; Ferris S; Kluger A; Goldman R; Griesing T; Kumar D; Richardson S;
    Neurology; 2004 Aug; 63(4):651-7. PubMed ID: 15326237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AD2000: design and conclusions.
    Howe I
    Lancet; 2004 Oct 2-8; 364(9441):1214-5; author reply 1216-7. PubMed ID: 15464174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.